• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Cadrenal Therapeutics Acquires eXIthera’s Factor XIa Inhibitors

    GLOBENEWSWIRE

    eXIthera Announces FDA Acceptance of IND Application for Ph2 Trial of EP-7041

    PRNEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.